IAM
HALO icon

Iridian Asset Management’s Halozyme HALO Stock Holding History

Iridian Asset Management’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-34,100
Closed -$605K – 84
2019
Q4 		$605K Buy
34,100
+20,600
+153% +$357K 0.01% 68
2019
Q3 		$209K Buy
+13,500
New +$222K ﹤0.01% 76

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Iridian Asset Management's HALO Position: Q4 2020 in Review

Iridian Asset Management sold out of Halozyme (HALO) in Q4 2020, closing a stake of 38,906 shares — an estimated $1.02M sold.

Iridian Asset Management first reported a position in HALO in Q3 2013 and held it in 29 quarters. The position peaked at $218M in Q2 2015. 342 funds tracked by Wall St. Rank hold HALO as of Q4 2020.

  • Iridian Asset Management reported no remaining Halozyme position as of Q4 2020 after selling out during the quarter.
  • Iridian Asset Management sold 38,906 Halozyme shares in Q4 2020, an estimated $1.02M.
  • Iridian Asset Management first reported a position in Halozyme in Q3 2013 and held it in 29 quarters.
  • Iridian Asset Management's Halozyme position peaked at $218M in Q2 2015.
  • 342 funds tracked by Wall St. Rank held Halozyme as of Q4 2020.

Based on Iridian Asset Management's 13F filing for Q4 2020, filed 8 Feb 2021.